Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging significant accounting irregularities and misleading disclosures that resulted in inflated profits and concealed losses [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Marex shares between May 16, 2024, and August 5, 2025 [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff [2]. - The lawsuit follows a report from NINGI Research that accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions [3][4]. Group 2: Allegations and Financial Discrepancies - The report highlighted multi-million-dollar discrepancies in intercompany receivables and loans, including a fabricated $17 million receivable and a subsidiary's profits inflated by 150% [4]. - It was alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure, which was used to generate non-cash trading profits [4]. Group 3: Market Reaction - Following the report's release, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31, indicating significant investor losses [5].
INVESTOR REMINDER: Berger Montague Notifies Marex Group plc Investors (NASDAQ: MRX) of a Class Action Lawsuit and Deadline